Literature DB >> 18573991

Synergism between TLRs and NOD1/2 in oral epithelial cells.

A Uehara1, H Takada.   

Abstract

Oral epithelium is the first barrier against oral bacteria in periodontal tissue. Oral epithelial cells constitutively express Toll-like receptors (TLRs) and NOD1/2, functional receptors which induce the production of antibacterial factors such as peptidoglycan recognition proteins (PGRPs) and beta-defensin 2, but not pro-inflammatory cytokines such as interleukin (IL)-8. In this study, we hypothesized that innate immune responses in the oral epithelium are enhanced in inflamed tissue. We found that NOD1 and NOD2 agonists, in combination with TLR agonists, synergistically induced production of PGRPs and of beta-defensin 2 in human oral epithelial cells via NF-kappaB. In contrast, co-stimulation with NOD1/2 and TLR ligands had no effect on the production of pro-inflammatory cytokines (IL-6, IL-8, and monocyte chemoattractant protein-1). These findings indicate that, in innate immune responses to invading microbes, a combination of signaling through TLRs and NODs leads to the synergistic activation of antibacterial responses in the oral epithelium.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18573991     DOI: 10.1177/154405910808700709

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  20 in total

Review 1.  Epithelial cells and innate antifungal defense.

Authors:  G Weindl; J Wagener; M Schaller
Journal:  J Dent Res       Date:  2010-04-15       Impact factor: 6.116

Review 2.  Microbial Nucleic Acid Sensing in Oral and Systemic Diseases.

Authors:  K E Crump; S E Sahingur
Journal:  J Dent Res       Date:  2015-10-05       Impact factor: 6.116

3.  NOD2 deficiency results in increased susceptibility to peptidoglycan-induced uveitis in mice.

Authors:  Holly L Rosenzweig; Kellen Galster; Emily E Vance; Joe Ensign-Lewis; Gabriel Nunez; Michael P Davey; James T Rosenbaum
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-09       Impact factor: 4.799

4.  HIV type 1 fails to trigger innate immune factor synthesis in differentiated oral epithelium.

Authors:  Wipawee Nittayananta; Florian Hladik; Mitchell Klausner; Socorro Harb; Beverly A Dale; Robert W Coombs
Journal:  AIDS Res Hum Retroviruses       Date:  2009-10       Impact factor: 2.205

5.  Combined stimulation of Toll-like receptor 5 and NOD1 strongly potentiates activity of NF-κB, resulting in enhanced innate immune reactions and resistance to Salmonella enterica serovar Typhimurium infection.

Authors:  Amir I Tukhvatulin; Ilya I Gitlin; Dmitry V Shcheblyakov; Natalia M Artemicheva; Lyudmila G Burdelya; Maxim M Shmarov; Boris S Naroditsky; Andrei V Gudkov; Alexander L Gintsburg; Denis Y Logunov
Journal:  Infect Immun       Date:  2013-07-29       Impact factor: 3.441

Review 6.  The oral microbial consortium's interaction with the periodontal innate defense system.

Authors:  Richard P Darveau
Journal:  DNA Cell Biol       Date:  2009-08       Impact factor: 3.311

Review 7.  Autonomous immunity in mucosal epithelial cells: fortifying the barrier against infection.

Authors:  Karen F Ross; Mark C Herzberg
Journal:  Microbes Infect       Date:  2016-03-19       Impact factor: 2.700

8.  NOD1 agonist iE-DAP reverses effects of cigarette smoke extract on NOD1 signal pathway in human oral mucosal epithelial cells.

Authors:  Yafan Gao; Wenhui Jiang; Yajie Qian; Qian Zhou; Hongliu Jiang; Xiang Wang; Wenmei Wang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

9.  NOD1 and NOD2 stimulation triggers innate immune responses of human periodontal ligament cells.

Authors:  Do-In Jeon; Se-Ra Park; Mee-Young Ahn; Sang-Gun Ahn; Jong-Hwan Park; Jung-Hoon Yoon
Journal:  Int J Mol Med       Date:  2012-01-03       Impact factor: 4.101

Review 10.  Oral Versus Gastrointestinal Mucosal Immune Niches in Homeostasis and Allostasis.

Authors:  Lina J Suárez; Silie Arboleda; Nikola Angelov; Roger M Arce
Journal:  Front Immunol       Date:  2021-07-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.